21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS
#902USE OF A CONJUGATE OF ANTI-CD47 ANTIBODY AND TOLL-LIKE RECEPTOR AGONIST
#903ANTI-ROR2 ANTIBODY-DRUG CONJUGATES
#904Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#905METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY
#906LIPID POLYSACCHARIDE AMINO ACID NANOPARTICLES AND USE THEREOF
#907TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF
#908COMPOSITION FOR INTERMITTENT DOSING OF CALCINEURIN INHIBITORS
#909ANTIMICROBIAL PEPTIDE COMPOUNDS AND METHODS OF USE
#910MICROBIAL CONSORTIA
#911COMPOSITIONS AND METHODS FOR IMPROVING VISION
#912NASAL COMPOSITIONS COMPRISING ALCAFTADINE
#913METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE
#914HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES
#915TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA
#916AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
#917METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUCTION
#918METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS
#919INHIBITION OF DIPEPTIDE REPEAT PROTEINS
#920METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#921METHOD FOR TREATING RENAL CELL CARCINOMA OR CANCER
#922PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF
#923ULTRASOUND RESPONSIVE NANOCLUSTER FOR CANCER TREATMENT AND METHOD FOR MANUFACTURING THE SAME
#924TICAGRELOR IV FORMULATIONS FOR USE IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA
#925COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS
#926DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
#927METHODS OF TREATING, AMELIORATING AND/OR PREVENTING WOUNDS
#928COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALT CANCER
#929PERSONALIZED TUMOR MARKERS
#930Methods of Treating PD-L1 Expressing Cancer
#931TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO
#932PROTEINS COMPRISING THE EXTRACELLULAR DOMAIN OF P75NTR
#933NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#934Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof
#935SMALL MOLECULE MODULATORS OF STAT6
#936NOVEL INHIBITORS
#937QUINOXALINEDIONE AND PYRIDO[2,3-B]PYRAZINE-2,3-DIONE B CELL LYMPHOMA 6 (BCL6) DEGRADERS AND USES THEREOF
#938COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF HIV
#939FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF
#940LYMPH DIRECTING PRODRUGS
#941APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS
#942COMPOSITION FOR PREVENTING OR TREATING CANCER, AND METHOD FOR PREVENTING OR TREATING CANCER BY USING SAME, HAVING ABSCOPAL EFFECT
#943METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE
#944C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS
#945MICROBIAL METABOLITES ON INTESTINAL INFLAMMATION
#946COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
#947SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#948PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#949CANNABINOID COMPOSITIONS AND METHODS OF USING
#950CANNABINOID COMPOSITIONS AND METHODS OF USING
#951COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
#952COMBINATION THERAPY FOR PREVENTING OR TREATING OBESITY
#953BRAIN HEALTH SUPPLEMENT
#954HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY
#955METHODS FOR THE TREATMENT OF PROLIFERATIVE GLOMERULONEPHRITIS
#956Inhibition of Oral Microbe Biofilms
#957Combination Of Curaxins And Immune Checkpoint Inhibitors For Treating Cancer
#958ISOTOPICALLY ENRICHED ANALOGS OF 5,6-METHYLENEDIOXY-2-AMINOINDANE (IMDAI)
#959COMPOSITIONS AND METHODS FOR SKIN CARE
#960STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE
#961MULTIPHASE ACTIVE SUBSTANCE PREPARATIONS
#962METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES
#963MULTI-MODALITY PLATFORM IMMUNOTHERAPY AND TUMOR-SPECIFIC T CELLS
#964Compositions and Methods for Inhibition of Factor XII Gene Expression
#965RNA INTERFERENCE OLIGONUCLEOTIDES FOR INHIBITING PERINEURONAL NETWORK FORMATION
#966Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#967ANTIBODIES AGAINST ILT2 AND USE THEREOF
#968HUMANIZED AND AFFINITY-MATURED ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE
#969SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS
#970Tetrahydropyranopyrazole Derivatives for the Treatment of Cancer and Viral Infections
#971TRICYCLIC COMPOUNDS AND USES THEREOF
#972TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF
#973PRMT5 INHIBITORS AND USES THEREOF
#974ANTIBACTERIAL COMPOUNDS, METHOD OF PRODUCTION AND USE THEREOF
#975N-Substituted Phenylalkylamines and Their Use as Therapeutic Agents
#976ACTIVE AGENT-ELUTING HEMOSTATIC AGENTS AND METHODS OF USE THEREOF
#977FORMULATIONS AND USES THEREOF
#978CD25-SPECIFIC ANTIBODIES AND USES THEREOF
#979USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK
#980Methods and Compositions for Treating Diabetes
#981PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
#982Compositions and Methods of Treatment for Various Conditions using High-Molecular Weight Hyaluronic Acid
#983INJECTABLE ANTIBIOTIC FORMULATIONS AND USES THEREOF
#984Prevention of Nausea and Vomiting from Antibody-Drug Conjugates and other Long-Acting Emetogenics
#985USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#986PHARMACEUTICAL COMPOSITION CONTAINING PLATINUM DRUGS OR PLATINUM DRUG COCRYSTALS, AND USE THEREOF
#987TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL
#988ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS
#989METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORS
#990ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS
#991METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS
#992USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER
#993PREVENTING AND TREATING MALARIA
#994COMPOSITIONS FOR AND METHODS OF PRECISION CANCER TREATMENT
#995CONSUMER PRODUCT TABLET USING DIRECT COMPRESSION
#996GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#997CANCER THERAPY WITH TGF-BETA-2 AND IRINOTECAN AGENTS
#998GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#999ANTI-CD1A ANTIBODIES
#1000ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE
#1001ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
#1002NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY
#1003COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#1004COMPOUNDS FOR TREATING LIGHT CHAIN AMYLOIDOSIS
#1005COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#1006Compositions of DNA Molecules Encoding Factor VIII, Methods of Making Thereof, and Methods of Use Thereof
#1007METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#1008COMPOSITIONS AND METHODS FOR HAIR TREATMENT
#1009MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS
#1010COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS
#1011A CANNABINOID MIXTURE WITH TERPENES FOR THE TREATMENT OF ANXIETY
#1012PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN
#1013ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING KIDNEY DISEASES AND KIDNEY-RELATED DISEASES
#1014Methods of Treating Diabetic Macular Edema
#1015METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE
#1016NOVEL DOSAGE AND FORMULATION
#1017Cannabis-Derived Flavonoids And Related Methods
#1018Chelating Agents for Use in Cancer Therapy
#1019COMPOSITIONS AND METHODS FOR TREATING HEARING AND OCULAR DISORDERS
#1020MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS
#1021ANTIMICROBIAL COMPOUNDS
#1022TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
#1023MULTI-TAIL TYPE IONIZABLE LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF
#1024DELIVERY SYSTEM
#1025NASAL PASSAGE INSERT AND PACKAGING ASSEMBLY THEREFOR
#1026METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
#1027METHODS INVOLVING DETECTING TNF STIMULATED GENE 6 (TSG-6) FOR IMPROVING ANTI-TUMOR RESPONSES TO IMMUNE THERAPY IN CANCER PATIENTS
#1028METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE
#1029ANTI-CD40 ANTIBODY, ANTI-PD-L1×CD40 BISPECIFIC ANTIBODY, AND USE THEREOF
#1030ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF
#1031Targeting Cells with a Combination of CXCR2 Inhibition and CD47 Blockade
#1032Anti-TRPM4 Antibody For Treating Stroke
#1033SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#1034NOVEL TUMOR ANTIGEN-TARGETING ANTICANCER AGENT
#1035BK VIRUS NEUTRALIZING ANTIBODIES
#1036BK VIRUS NEUTRALIZING ANTIBODIES
#1037COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#1038COMPOUNDS AND COMPOSITIONS FOR EYE TREATMENTS
#1039COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#1040IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE
#1041OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF
#1042Combination Therapy for Treatment of Muscle Loss Due to Obesity Treatments
#1043COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#1044PHARMACEUTICAL COMPOSITION AND METHODS FOR MODULATING INFLAMMATION AND OXIDATIVE STRESS
#1045COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES
#1046SOTORASIB DOSING REGIMEN
#1047TREATMENT OF CANCER UTILIZING AN IDENTIFIED ADENOSINE FINGERPRINT
#1048METHODS OF TREATING A RAS PROTEIN-RELATED DISEASE OR DISORDER
#1049METHOD OF TREATING ALZHEIMER’S DISEASE
#1050PHARMACEUTICAL RESINATE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#1051SMALL MOLECULES AND METHODS FOR INDUCING CARDIOMYOCYTE PROLIFERATION
#1052COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION
#1053OBLIGATE PAIRING OF ORTHOSTERIC AND NON-ORTHOSTERIC GABA LIGANDS IN PHARMACEUTICAL FORMULATIONS
#10541-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE FOR TREATING MAJOR DEPRESSIVE DISORDER
#1055ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#1056METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES
#1057METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES
#1058SHEAR-THINNING COMPOSITIONS FOR ABLATION
#1059SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT CANCER
#1060SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY
#1061COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS
#1062Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)
#1063MULTISPECIFIC ANTIBODIES TARGETING MULTIPLE EPITOPES ON THE HIV-1 ENVELOPE
#1064SHORT SYNTHETIC PEPTIDES AND USES THEREOF IN THE TREATMENT OF ENTEROVIRUS INFECTION
#1065CD73 INHIBITORS
#1066Antiviral Heterocyclic Compounds
#1067SMALL MOLECULE INHIBITORS OF BCR-ABL
#1068MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF
#1069MULTIPLE KINASE DEGRADERS, COMPOSITIONS COMPRISING THE DEGRADER, AND METHODS OF USING THE SAME
#1070NOVEL RAS INHIBITORS
#1071COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#1072SELECTIVE HDAC6 INHIBITOR
#1073FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#1074GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
#1075FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
#1076COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR
#1077COMPOSITIONS FOR TREATING ADDICTION
#1078TREATING AUTOIMMUNE DISEASES WITH INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR LIGAND CONJUGATED TO AN AGENT
#1079GOSERELIN IMPLANT DOSING REGIMENS FOR IMPROVED PATIENT COMPLIANCE
#1080MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF
#1081IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES
#1082METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY
#1083PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#1084PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#10851-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF
#1086METHODS OF TREATING EPILEPSY AND REDUCING THE INCIDENCE OF SEIZURES
#1087TREATMENT OF MITOCHONDRIAL DISEASES WITH A CNS-PENETRANT SGC STIMULATOR ZAGOCIGUAT
#1088COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#1089COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS
#1090TOPICAL ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) FOR TREATING EYE CONDITIONS
#1091FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT
#1092THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR
#1093FORMULATIONS FOR PROMOTING HYDRATION AND METHODS OF USE THEREOF
#1094Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto
#1095METHODS FOR TREATING CANCER
#1096METHODS FOR TREATING CANCER
#1097PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
#1098DEVICES, SYSTEMS, AND METHODS FOR IMPROVED BONE REMODELING
#1099SCREENING MODELS AND METHODS OF CANCER TREATMENT
#1100Thrombolytic Protease Resistant ADAMTS13 Mutants
#1101PH-SWITCHABLE HYDROGEL
#1102COMBINATION THERAPIES FOR TREATING HYPERPROLIFERATIVE DISORDERS
#1103ANTI- SIGLEC-15 BINDING MOLECULES AND METHODS OF USE
#1104APOMORPHINE PRODRUGS AND USES THEREOF
#1105DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
#1106AMIDE COMPOUNDS AND USES THEREOF
#11074-PIVALOYLOXY-N-METHYLTRYPTAMMONIUM CHLORIDE
#1108ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF
#1109CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
#1110PHARMACEUTICAL COMBINATIONS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES
#1111IMMUNOEFFECTOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS GENETICALLY ENGINEERED WITH MEMBRANE BOUND IL12 AND USES THEREOF
#1112USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER
#1113METHODS FOR TREATING LUPUS NEPHRITIS USING FCRN ANTAGONISTS
#1114USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSIS
#1115ECHINOCANDIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#1116ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION
#1117METHOD FOR REDUCING THE INCIDENCE OF PECTORAL MYOPATHY IN POULTRY FEED
#1118Therapeutic Composition and Methods
#1119CYTOTOXIC FLUOROPYRIMIDINE POLYMERS AND METHODS OF USE THEREOF
#1120DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
#1121DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)
#1122PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORS
#1123NOVEL METHODS
#1124ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES
#1125Treatment or Reversal of Treatment Resistant Depression and Related Central Nervous System (CNS) Inflammatory Conditions with a JAK Inhibitor
#1126NOVEL RAS INHIBITORS
#1127COMPOSITIONS OF AGPAT4 INHIBITORS AND METHODS OF USING THEREOF TO TREAT CANCER
#1128ANTI-CD38 FUSION PROTEIN FORMULATION
#1129TREATMENT OF ATOPIC DERMATITIS
#1130TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
#1131ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
#1132COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#1133Keratin Protein Extracts, Compositions, Methods and Uses Thereof
#1134TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY
#1135C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
#1136NITROGEN-CONTAINING CHAIN COMPOUND, PREPARATION METHOD, COMPOSITION CONTAINING SAID COMPOUND, AND USE THEREOF
#1137Nanoclusters Functionalized with Adenosine Triphosphate or an Analogue and Their Use
#1138ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS
#1139THERAPEUTIC ANNEXIN-DRUG CONJUGATES AND METHODS OF USE
#1140COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC DISEASE STATES AND CANCER
#1141TOPICAL COMPOSITION
#1142ENGINEERED VIRUS
#1143PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF
#1144TUMOR NEOANTIGENIC PEPTIDES AND USES THEREOF
#1145SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE
#1146SUBSTITUTED HETEROCYCLIC COMPOUND DERIVATIVES AND THEIR PHARMACEUTICAL USE
#1147Cancer Diagnostic and Treatment
#1148TREATMENT OF MUSCLE ATROPHY USING GSK-3 INHIBITORS
#1149TRPV2 CHANNEL BLOCKERS AND USE THEREOF
#1150NEURORESTORATION COMPOSITIONS IMPLEMENTING MULTIPLE NEUROPLASTICITY INDUCING MECHANISMS OF ACTION
#1151Dosage Regimen for the Treatment of Cancer
#1152TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
#1153METHODS OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH ATRASENTAN
#1154LYMPH DIRECTING PRODRUGS
#1155Methods Of Treatment Of Inflammation Related Conditions Using Pluripotent Anti-inflammatory And Metabolic Modulators
#1156HIGHLY ELASTIC PATCHES AND MASKS FOR DELIVERY OF THERAPEUTIC AGENTS
#1157Biomimetic Drug Delivery Particles
#1158TAMPER RESISTANT DOSAGE FORMS
#1159LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF
#1160METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#1161METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION
#11625-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER
#1163METHODS OF TREATING CANCER BY ADMINISTERING A NEOADJUVANT PD-1 INHIBITOR
#1164ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
#1165MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#1166DUAL SPECIFIC ANTIBODIES
#1167URSOLIC ACID DIETHANOLAMINE SALT
#1168COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE
#1169ROCK INHIBITORS AND USES THEREOF
#1170HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES
#1171METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P
#1172ANTIBODY-MEDIATED CONDITIONING WITH IMMUNOSUPPRESSION TO ENABLE ALLOGENEIC TRANSPLANTATION
#1173PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE
#1174VACCINATION IN NEWBORNS AND INFANTS
#1175VACCINATION IN NEWBORNS AND INFANTS
#1176COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE
#1177TOPICAL THERAPEUTIC FORMULATIONS
#1178COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS
#1179BINDING MOLECULES TO TUMOR ASSOCIATED MACROPHAGES AND METHODS OF USE
#1180METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING BACILLUS AMYLOLIQUEFACIENS
#1181ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#1182PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1183CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#11844-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
#1185METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE
#1186THERAPIES WITH PPAR AGONISTS AND FGFR4 INHIBITORS
#1187NOVEL COMBINATION THERAPY OF CRENOLANIB AND APOPTOSIS PATHWAY AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
#1188COMPOUND AND USE THEREOF IN PREVENTING OR TREATING RADIATION DAMAGE
#1189New pharmaceutical compounds, methods and uses thereof
#1190METHODS OF INCREASING LYMPHOCYTE TRAFFICKING TO THE COLON BY STIMULATING RETINOIC ACID RECEPTORS AND ARYL HYDROCARBON RECEPTORS
#1191IMMUNE HEALTH IMPROVERS
#1192COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS
#1193Extended Duration Local Anesthetic Formulation
#1194ASYMMETRIC SYNTHESIS AND USES OF COMPOUNDS IN DISEASE TREATMENTS
#1195THERAPEUTIC COMPOSITIONS
#1196METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER
#1197Arterial Application of Low Dose Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Transient Opening
#1198COMPOSITION COMPRISING A MIXTURE OF AT LEAST ONE OIL AND ONE OR MORE SEMIFLUORINATED ALKANES, A USE OF THE COMPOSITION FOR TREATING A DISEASE AS WELL AS A METHOD OF PRODUCING THE COMPOSITION AND CORRESPONDING KITS
#1199PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#1200CHEWABLE PHARMACEUTICAL DOSAGE FORMS